BRIEFING

 Dydrogesterone Tablets. This proposal is based on the version of the monograph official prior to 2013. It is proposed to omit this monograph for the following reasons:

1. No drug products formulated as defined under Dydrogesterone Tablets are currently marketed in the United States.

2. The drug product is currently not on the list for approved veterinary medicine in the United States.

 (SM5: N. Myers)

 Correspondence Number—C328440